Search Results - "Sood, A.K."

Chemical Functionalization of Graphene To Augment Stem Cell Osteogenesis and Inhibit Biofilm Formation on Polymer Composites for Orthopedic Applications by Kumar, Sachin, Raj, Shammy, Kolanthai, Elayaraja, Sood, A.K, Sampath, S, Chatterjee, Kaushik

“…Toward designing the next generation of resorbable biomaterials for orthopedic applications, we studied poly­(ε-caprolactone) (PCL) composites containing…”
Get full text

Engineering a 3D MoS2 foam using keratin exfoliated nanosheets by Agarwal, Vipul, Varghese, Neethu, Dasgupta, Subho, Sood, A.K., Chatterjee, Kaushik

“…•MoS2 was exfoliated using keratin as a surfactant.•Keratin exfoliated MoS2 has the shelf life of over one year.•Keratin exfoliated MoS2 exhibited the high…”
Get full text

Sensitive detection of C-reactive protein using optical fiber Bragg gratings by Sridevi, S., Vasu, K.S., Asokan, S., Sood, A.K.

“…An accurate and highly sensitive sensor platform has been demonstrated for the detection of C-reactive protein (CRP) using optical fiber Bragg gratings (FBGs)…”
Get full text

3D scaffold alters cellular response to graphene in a polymer composite for orthopedic applications by Kumar, Sachin, Azam, Dilkash, Raj, Shammy, Kolanthai, Elayaraja, Vasu, K.S., Sood, A.K., Chatterjee, Kaushik

“…Graphene-based polymer nanocomposites are being studied for biomedical applications. Polymer nanocomposites can be processed differently to generate planar…”
Get full text

Non-enzymatic electronic detection of glucose using aminophenylboronic acid functionalized reduced graphene oxide by Vasu, K.S., Sridevi, S., Sampath, S., Sood, A.K.

“…•The electronic detection of glucose molecules using FET devices made of APBA–RGO complex is demonstrated.•APBA–RGO complex was prepared in both covalent and…”
Get full text

Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer by Coleman, R.L, Tung, C.S, Munsell, M.F, Sood, A.K

Get full text

Overcoming stress effects: A prospective feasibility trial of beta-blockers with upfront ovarian cancer therapy by Thaker, P.H, Kuroki, L.M, Hu, W, Zighelboim, I, Ramondetta, L.M, Hagemann, A.R, Massad, L.S, Powell, M.A, Mutch, D.G, Sood, A.K

Get full text

Less is more: Macrophage depletion after adaptive resistance improves anti-VEGF therapy by Lyons, Y.A, Pradeep, S, Hansen, J.M, Dood, R.L, Wu, S, Wagner, M.J, Previs, R.A, Hu, W, Coleman, R.L, Sood, A.K

Get full text

Dll3 alterations predict poor survival in gynecological cancers by Hu, W, Ivan, C, Lyons, Y.A, Hansen, J.M, Dood, R.L, Wagner, M.J, Previs, R.A, Frumovitz, M, Coleman, R.L, Sood, A.K

Get full text

Pretty fly for GPI: Altered carbohydrate metabolism in ovarian cancer by Previs, R.A, Moss, T.J, Zand, B, Hansen, J.M, Dood, R.L, Armaiz-Pena, G.N, Lyons, Y.A, Coleman, R.L, Sood, A.K

Get full text

Knocking out stress: A systems-based identification of optimal drug combinations to improve ovarian cancer outcomes by Dood, R.L, Nagaraja, A.S, Lyons, Y.A, Hansen, J.M, Previs, R.A, Jackson, D.B, Coleman, R.L, Sood, A.K

Get full text

The Role of Neuroinflammation in Tumor-Induced Fatigue by Grossberg, A, Vichaya, E, Christian, D, Molkentine, J, Vermeer, D.W, Heijnen, C, Kavelaars, A, Lee, J.H, Sood, A.K, Dantzer, R

Get full text

Homologous recombination deficiency in endometrioid uterine cancer: An unrecognized phenomenon by Baggerly, K.A, Wang, Y, Wu, S, Previs, R.A, Zand, B, Dalton, H.J, Hu, W, Coleman, R.L, Sood, A.K

Get full text

PTEN loss predicts response to Notch pathway inhibition in endometrial cancer by Hansen, J.M, Previs, R.A, Lyons, Y.A, Wang, Y, Ivan, C, Hu, W, Baggerly, K.A, Sood, A.K

Get full text

Personalized surgical therapy for advanced ovarian cancer: R0 resection after neoadjuvant chemotherapy is associated with decreased event-free survival compared with primary cytoreductive surgery by Nick, A.M, Coleman, R.L, Ramirez, P.T, Lu, K.H, Schmeler, K.M, Burzawa, J.K, Soliman, P.T, Rangel, K.M, Munsell, M.F, Sood, A.K

Get full text

Personalizing surgical therapy for advanced ovarian cancer: CT imaging may not predict disease resectability by Nick, A.M, Ganeshan, D, Iyer, R, Bhosale, P, Munsell, M.F, Schmeler, K.M, Burzawa, J.K, Soliman, P.T, Coleman, R.L, Sood, A.K

Get full text

Improving hormonal therapy in uterine cancer: Efficacy of onapristone (phosphor-PR) and trametinib by Huang, Y, Hu, W, Huang, J, Pradeep, S, Dalton, H.J, Previs, R.A, Hansen, J.M, Nick, A.M, Coleman, R.L, Sood, A.K

Get full text

Modeling bad behavior: Overcoming anti-VEGF resistance in vivo by Dalton, H.J, Pradeep, S, Previs, R.A, Hansen, J.M, Rupaimoole, R, Zand, B, Nick, A.M, Hu, W, Coleman, R.L, Sood, A.K

Get full text

Two to tango: Biological activity and companion predictive markers for a novel dual AKT and P70S6K inhibitor in ovarian and uterine malignancies by Previs, R.A, Armaiz-Pena, G.N, Ivan, C, Dalton, H.J, Huang, J, Hansen, J.M, Hu, W, Coleman, R.L, Sood, A.K

Get full text

Off-target effects of erythropoietin stimulate ovarian cancer via EphB4 by Sood, A.K, Pradeep, S, Huang, J, Nick, A.M, Brock, S, Hansen, J, Previs, R.A, Hu, W, Coleman, R.L, Jackson, D.B

Get full text